[The effects of 3-(beta-diethylaminoethyl)-4-methyl-7-carbothoxymethoxy-2-oxo-(1,2-chromene)-hydrochloride and nitroglycerin on cardiovascular dynamics in healthy and coronary diseased hearts].
作者信息
Pippig L, Schneider K W
出版信息
Arzneimittelforschung. 1965 Sep;15(9):1008-19.
PMID:4955785
Abstract
摘要
相似文献
1
2
[Double-blind clinical trial of a new coronary-active drug, MD 6753].
Minerva Cardioangiol. 1974 Oct;22(10):683-90.
3
Effects of nitroglycerin on myocardial ischemia and its clinical manifestations in severe coronary heart disease.
Bibl Cardiol. 1985(39):118-28.
4
[Therapy of coronary insufficiency with carbochromen].
Arzneimittelforschung. 1970 Mar;20:456-9.
5
[Carbochromen in therapy of acute and chronic coronary insufficiency].
Arzneimittelforschung. 1970 Mar;20:459-60.
6
[Treatment of the intermediate syndrome].
Arq Bras Cardiol. 1979 Feb;32(2):71-4.
7
[The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
Eksp Klin Farmakol. 1996 Jul-Aug;59(4):18-20.
8
[Pharmacologic properties and indications of modern vasodilator agents. 2: Indications and side effects of vasodilator agents].
Z Arztl Fortbild (Jena). 1985;79(20):867-73.
9
[Action of Carbocromene in acute and chronic coronary insufficiency].
Sem Hop. 1966 Dec 15;42:Suppl:5-10.
10
[Influence of "coronary dilators" on the pathological St-T segmental changes in the ECG].
Med Klin. 1967 Jun 16;62(24):945-50.
引用本文的文献
1
[Pharmacodynamic effect on coronary blood circulation and metabolism of the human heart. Studies with 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromen)-hydrochloride].
Klin Wochenschr. 1967 Apr 1;45(7):333-53. doi: 10.1007/BF01738741.
Zotero 插件